Global Probiotics Market Outlook, 2031
The Global Probiotics Market is segmented into By Product Type (Probiotics Food and Beverages, Probiotics Dietary Supplements, Animal Feed); By Distribution Channel (Hypermarkets and Supermarkets, Pharmacies/Drugstores, Convenience Stores, Specialty Stores, Online, Others); By End-Use (Human Probiotics, Animal Probiotics); By Ingredient Type (Bacteria, Yeast).
- Bonafide Research
- 17-01-2026
- Pages : 198
- Figures : 36
- Tables : 112
- Region : Global
- Category : Food & Beverages
- Food
The Global Probiotics market was valued at more than USD 81.07 billion in 2025 and is expected to reach USD 127.57 billion by 2031, driven by growing digestive health awareness.
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Market Size (2025) USD 81.07 Billion
- Market Size (2031) USD 127.57 Billion
- CAGR (2026-2031) 8.05%
- Largest Market Asia-Pacific
- Fastest Market Asia-Pacific
- Format
Featured Companies
- 1. Nestle SA
- 2. Kerry Group
- 3. Arla Food
- 4. Danone SA
- 5. Archer-Daniels-Midland Company
- 6. PepsiCo Inc.
- 7. Yakult Honsha Co. Ltd.
- 8. Lonza Group AG
- 9. Evonik Industries AG
- More...
Probiotics Market Analysis
The global probiotics market today represents a convergence of microbiology research, preventive healthcare thinking, and evolving consumer nutrition habits rather than a short lived wellness phenomenon. Its position has been shaped by decades of scientific progress that clarified the distinction between traditional fermented foods and probiotics defined by specific, viable microorganisms with documented functional relevance. Early adoption rooted in fermented dairy across Europe and Asia gradually expanded as global dietary patterns shifted toward processed foods, higher antibiotic exposure, and lifestyle related digestive sensitivity. Academic research from organizations such as the World Gastroenterology Organisation and leading medical universities contributed to broader recognition that probiotic benefits depend on strain identity, dosage, and survivability through the digestive system. Preventive health awareness accelerated worldwide as populations aged and healthcare systems emphasized self-management of digestive comfort, immune balance, and metabolic wellbeing. Probiotics evolved from refrigerator dependent yogurts into shelf stable capsules, powders, sachets, and functional foods that fit daily routines across regions with diverse climates and consumption habits. Cultural differences shaped adoption pathways, with some regions relying heavily on physician guidance while others leaned toward nutritionists and pharmacy counseling. Public discussion around the gut microbiome expanded to include its connection with immunity, stress response, and systemic health, reinforcing probiotics as part of long term wellness strategies. Regulatory diversity across regions further influenced product development, encouraging companies to prioritize documentation, safety, and stability. Demand for dietary supplements is growing in Asia Pacific, especially in China. This growth is driven by the “fourth meal” idea, which refers to taking vitamins and dietary supplements daily as the “fourth meal”, has gained traction amongst Chinese consumers. Immunity-boosting and long-COVID symptomtackling products are now the top-choice supplements for those prioritizing their health, sparking a wave of dynamic development. According to the research report "Global Probiotics Market Outlook, 2030," published by Bonafide Research, the Global Probiotics market was valued at more than USD 81.07 Billion in 2025, and expected to reach a market size of more than USD 127.57 Billion by 2031 with the CAGR of 8.05% from 2026-2031. The global probiotics market is defined by extensive corporate investment, cross border research collaboration, and ongoing product development aligned with regulatory frameworks. Chr Hansen emerged as a leading strain developer supplying documented probiotic cultures used across dairy, supplements, and functional foods worldwide. Danone strengthened probiotic visibility through long term digestive health research translated into fermented food products adapted for multiple regions. Nestlé Health Science expanded medical nutrition portfolios incorporating probiotics for clinical and preventive use, bridging consumer wellness and healthcare settings. Yakult Honsha maintained a strong global presence by promoting daily probiotic consumption supported by proprietary strain research and education initiatives. International Flavors and Fragrances advanced fermentation and stabilization technologies following integration of DuPont Nutrition and Biosciences capabilities. Probiotical established itself as a specialized manufacturer supplying finished probiotic formulations and strain development services across Europe and beyond. Pharmaceutical companies including Bayer and Abbott integrated probiotics into digestive and pediatric nutrition solutions positioned alongside established health products. Regulatory bodies across regions prompted investments in genetic strain identification, stability testing, and controlled health communication. Retail expansion through pharmacies, supermarkets, and digital platforms supported broader accessibility, while subscription based models reinforced adherence. Recent developments included increased focus on multi strain formulations, heat stable technologies, and research into postbiotic applications.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamic
Market Drivers • Preventive Healthcare Shift:Saudi Arabia is experiencing a strong transition toward preventive healthcare driven by Vision 2030 and rising awareness of lifestyle related conditions such as digestive disorders obesity and diabetes. Hospitals and physicians increasingly emphasize gut health as part of routine wellness especially during antibiotic use. Probiotics are frequently recommended alongside dietary changes which supports sustained demand. Expansion of modern pharmacy chains and hospital based nutrition counseling further reinforces probiotics as part of everyday health management rather than occasional supplementation. • Urban Lifestyle Changes:Rapid urbanization in cities like Riyadh Jeddah and Dammam has altered dietary patterns toward higher consumption of processed foods and lower fiber intake. This shift has increased digestive discomfort and demand for gut balancing solutions. Working professionals and families seek convenient nutrition formats such as capsules sachets and fortified dairy. Probiotics fit well into this need as they align with busy lifestyles while addressing digestive and immune support concerns linked to urban living. Market Challenges • Regulatory Compliance Pressure:Probiotic products in Saudi Arabia must comply with strict registration and approval processes enforced by the Saudi Food and Drug Authority. Requirements around safety documentation labeling and health communication increase time to market and compliance costs. Smaller brands often face challenges in meeting these standards which can limit product variety. Restrictions on disease related claims also make consumer education more complex and require careful formulation and marketing alignment. • Consumer Knowledge Gaps:Despite growing awareness many consumers still struggle to differentiate between probiotics food supplements and traditional fermented products. Limited understanding of strain specificity and usage duration can lead to inconsistent results which affects repeat purchasing. Reliance on informal advice rather than structured guidance in some retail settings contributes to confusion. This knowledge gap requires sustained education through pharmacists and healthcare professionals to build long term consumer trust. Market Trends • Pharmacy Led Adoption:Pharmacies in Saudi Arabia such as large national chains increasingly act as primary points of probiotic recommendation. Pharmacist guidance plays a major role in product selection especially for digestive recovery pediatric use and immune support. This trend reflects consumer preference for medically endorsed supplements rather than influencer driven products. As pharmacy networks expand probiotics gain stronger credibility and consistent usage patterns. • Heat Stable Formulations:Saudi Arabia’s climate has accelerated interest in shelf stable and heat resistant probiotic formats that maintain viability without cold storage. Manufacturers are adopting encapsulation and spore forming strains suited for high temperatures. These formats improve product reliability during transport and storage and expand accessibility beyond refrigerated retail. This trend supports broader geographic distribution and aligns with regional logistics conditions.
Probiotics Segmentation
| By Product Type | Probiotics Food and Beverages | |
| Probiotics Dietary Supplements | ||
| Animal Feed | ||
| By Distribution channel | Hypermarkets and Supermarkets | |
| Pharmacies/Drugstores | ||
| Convenience Stores | ||
| Specialty stores | ||
| Online | ||
| Others | ||
| By End-use | Human Probiotics | |
| Animal Probiotics | ||
| By Ingredient Type | Bacteria | |
| Yeast | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Probiotics dietary supplements lead globally because they offer controlled dosage, strain specificity, and consistent efficacy across diverse populations and use cases. Probiotic dietary supplements have emerged as the leading product type globally because they address limitations inherent in food based probiotics while aligning closely with medical guidance and modern lifestyles. Supplements allow manufacturers to deliver clearly identified strains such as Lactobacillus rhamnosus GG or Bifidobacterium animalis BB 12 in precise quantities that remain stable through shelf life, something difficult to guarantee in fermented foods where bacterial counts can fluctuate due to storage conditions and processing. Healthcare professionals across regions often recommend supplements during antibiotic therapy, digestive disorders, and immune recovery because capsules, sachets, and powders provide predictable intake and ease of compliance. Supplements also bypass dietary restrictions such as lactose intolerance and sugar avoidance, expanding accessibility beyond dairy consumers. In hospitals and pharmacies worldwide, probiotic supplements are integrated into medical nutrition protocols for pediatrics, geriatrics, and post illness care, reinforcing trust and repeat use. The rise of clinical studies conducted on supplement formats rather than foods has further strengthened confidence, as most strain specific human trials use encapsulated or powdered delivery systems. Supplements also adapt well to innovation including delayed release capsules, spore forming strains, and synbiotic combinations, allowing continuous product evolution without changing eating habits. Global urbanization and time constrained routines favor supplements that can be taken quickly without refrigeration or meal pairing. These practical and clinical advantages collectively explain why dietary supplements have become the dominant form through which consumers worldwide access probiotics for consistent and outcome oriented health support. Hypermarkets and supermarkets lead distribution globally because they integrate probiotics into everyday shopping routines with high visibility, trust, and accessibility. Hypermarkets and supermarkets dominate probiotic distribution worldwide because they seamlessly embed probiotic consumption into daily food purchasing behavior rather than positioning it as a specialized or medical activity. Large retail chains such as Walmart, Carrefour, Tesco, and AEON provide extensive refrigerated and shelf stable space where probiotic yogurts, fermented drinks, and supplements are encountered during routine grocery trips. This normalizes probiotics as part of everyday nutrition rather than occasional treatment. These stores offer strong cold chain infrastructure which is critical for dairy based probiotics, ensuring product integrity and consumer confidence. Supermarkets also allow side by side comparison of brands formats and benefits, encouraging trial and repeat purchases. Promotional activities such as in store sampling and bundled health product placement further accelerate adoption. Trust plays a significant role as consumers often associate large retailers with regulatory compliance and product safety, particularly in regions where food standards are strictly enforced. Supermarkets also serve diverse demographics including families elderly consumers and urban professionals, enabling probiotics to reach broad population segments simultaneously. In many regions pharmacists are not always the first point of contact, making supermarkets the most consistent exposure point for probiotic products. The expansion of private label probiotic yogurts and drinks by major retailers has also increased affordability and availability. These structural and behavioral factors explain why hypermarkets and supermarkets remain the leading global channel for probiotic distribution. Human probiotics lead end use globally because digestive and immune health needs directly affect daily quality of life across all age groups. Human probiotics dominate global end use because gut health is directly linked to common and recurring health concerns experienced by people worldwide, including digestion irregularities, immune vulnerability, and antibiotic related imbalance. Unlike animal applications which are limited to agricultural or veterinary settings, human probiotics are relevant to infants, children, adults, and the elderly, creating continuous and lifelong demand. Medical communities globally recognize the role of gut microbiota in nutrient absorption and immune modulation, leading to widespread recommendation of probiotics during illness recovery and preventive care. Pediatric use is especially prominent as probiotics are often advised to manage digestive sensitivity during early development. Adults increasingly use probiotics to counter diet related discomfort associated with processed foods and stress. Aging populations rely on probiotics to maintain digestive regularity and immune resilience. Human probiotics are also integrated into functional foods beverages and supplements, making them accessible across cultural and economic contexts. Clinical research largely focuses on human outcomes such as bowel regularity immune response and microbiome balance, reinforcing legitimacy and awareness. Public health discussions around the gut brain axis have further expanded relevance by linking microbiota balance to mental wellbeing. These widespread physiological and lifestyle connections explain why human probiotics remain the dominant end use globally. Bacteria lead ingredient type globally because most clinically validated probiotic benefits are associated with bacterial strains rather than other microorganisms. Bacterial probiotics dominate the global market because the majority of scientific evidence supporting probiotic functionality is based on bacterial strains. Groups such as Lactobacillus and Bifidobacterium have been studied extensively for decades across human clinical trials evaluating digestion immune support and microbiome balance. These bacteria naturally inhabit the human gut which makes their supplementation biologically relevant and well tolerated. Regulatory authorities and scientific organizations often reference bacterial strains when defining probiotics, reinforcing their central role. Bacterial probiotics are versatile and can be incorporated into foods supplements and medical nutrition products with established fermentation techniques. Their compatibility with dairy and plant based matrices enables wide application across cultures. Manufacturers can selectively culture strains with specific survivability and adhesion properties, enabling targeted formulation for different health needs. Advances in microencapsulation and stability testing have further improved bacterial viability through processing and digestion. Yeast probiotics such as Saccharomyces boulardii serve important but narrower applications, primarily in antibiotic associated digestive support. The breadth of research application versatility and regulatory familiarity explains why bacteria remain the leading ingredient type globally in probiotics.
to Download this information in a PDF
Probiotics Market Regional Insights
APAC leads globally because traditional fermented food consumption, population scale, and rapid functional nutrition adoption converge in the region. The Asia Pacific region leads the global probiotics market due to a unique combination of cultural dietary habits demographic scale and accelerating health awareness. Countries such as Japan China South Korea and India have long histories of consuming fermented foods like yogurt kimchi miso and fermented milk drinks, creating inherent familiarity with beneficial microorganisms. This cultural foundation lowers adoption barriers compared to regions where probiotics are perceived as novel supplements. APAC also contains a large and diverse population base with rising urbanization and dietary transitions that increase digestive health concerns. Governments and healthcare institutions in countries like Japan and China actively promote functional foods as part of preventive health strategies. Japan in particular pioneered daily probiotic consumption through fermented milk drinks consumed across generations. Rapid growth of middle class consumers has increased willingness to invest in health focused foods and supplements. Strong domestic manufacturing capabilities support large scale probiotic production and innovation tailored to local diets. Retail expansion through supermarkets pharmacies and digital platforms further accelerates accessibility. Pediatric and elderly nutrition play a significant role in regional demand due to family oriented healthcare practices. These interconnected cultural demographic and structural factors collectively explain why APAC remains the leading region in the global probiotics market.
to Download this information in a PDF
Key Development
• In July 2025, Pepsi Prebiotic Cola, launched in Original Cola and Cherry Vanilla flavors, offers a reinvention of the traditional cola experience, reinforcing the brand's commitment to providing choice across its portfolio. • In January 2025, Hebrew SeniorLife is conducting a clinical food trial to test the effectiveness of a probiotic and prebiotic combination, BondiaÒ, in managing bone health in women over 60. • In May 2024, Nestlé Health Science, a global leader in nutritional science, acquired a majority stake in Persona Nutrition, a personalized nutrition company, to expand its probiotics offerings and enhance its digital health capabilities. • In April 2025, the European Commission approved the use of Lactobacillus rhamnosus GG as a functional ingredient in foods and dietary supplements, paving the way for increased market opportunities for probiotics manufacturers in Europe. • In March 2024, Chr. Hansen, a leading bioscience company, and FrieslandCampina, a global dairy cooperative, joined forces to create a new joint venture, Probiotics & Health, to develop and produce probiotic ingredients for the food and beverage industry. • In January 2024, Danone Manifesto Ventures, the venture capital arm of Danone, announced a strategic investment in Seedlip, a leading producer of non-alcoholic spirits, to expand its presence in the functional beverages market and strengthen its probiotics offerings.
Companies Mentioned
- Nestle SA
- Kerry Group
- Arla Food
- Danone SA
- Archer-Daniels-Midland Company
- PepsiCo Inc.
- Yakult Honsha Co. Ltd.
- Lonza Group AG
- Evonik Industries AG
- International Flavors & Fragrances (IFF)
- Lallemand Inc.
- Lifeway Foods, Inc
- AB BIOTICS
- Probi AB
- Sacco System
- Mother Dairy
- Morinaga Milk Industry Co., Ltd
- Novonesis
- BioGaia AB
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Global Probiotics Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Region
- 6.3. Market Size and Forecast, By Geography
- 6.4. Market Size and Forecast, By Product Type
- 6.5. Market Size and Forecast, By Distribution channel
- 6.6. Market Size and Forecast, By End-use
- 6.7. Market Size and Forecast, By Ingredient Type
- 7. North America Probiotics Market Outlook
- 7.1. Market Size By Value
- 7.2. Market Share By Country
- 7.3. Market Size and Forecast, By Product Type
- 7.4. Market Size and Forecast, By Distribution channel
- 7.5. Market Size and Forecast, By End-use
- 7.6. Market Size and Forecast, By Ingredient Type
- 7.7. United States Probiotics Market Outlook
- 7.7.1. Market Size by Value
- 7.7.2. Market Size and Forecast By Product Type
- 7.7.3. Market Size and Forecast By Distribution channel
- 7.7.4. Market Size and Forecast By End-use
- 7.7.5. Market Size and Forecast By Ingredient Type
- 7.8. Canada Probiotics Market Outlook
- 7.8.1. Market Size by Value
- 7.8.2. Market Size and Forecast By Product Type
- 7.8.3. Market Size and Forecast By Distribution channel
- 7.8.4. Market Size and Forecast By End-use
- 7.8.5. Market Size and Forecast By Ingredient Type
- 7.9. Mexico Probiotics Market Outlook
- 7.9.1. Market Size by Value
- 7.9.2. Market Size and Forecast By Product Type
- 7.9.3. Market Size and Forecast By Distribution channel
- 7.9.4. Market Size and Forecast By End-use
- 7.9.5. Market Size and Forecast By Ingredient Type
- 8. Europe Probiotics Market Outlook
- 8.1. Market Size By Value
- 8.2. Market Share By Country
- 8.3. Market Size and Forecast, By Product Type
- 8.4. Market Size and Forecast, By Distribution channel
- 8.5. Market Size and Forecast, By End-use
- 8.6. Market Size and Forecast, By Ingredient Type
- 8.7. Germany Probiotics Market Outlook
- 8.7.1. Market Size by Value
- 8.7.2. Market Size and Forecast By Product Type
- 8.7.3. Market Size and Forecast By Distribution channel
- 8.7.4. Market Size and Forecast By End-use
- 8.7.5. Market Size and Forecast By Ingredient Type
- 8.8. United Kingdom (UK) Probiotics Market Outlook
- 8.8.1. Market Size by Value
- 8.8.2. Market Size and Forecast By Product Type
- 8.8.3. Market Size and Forecast By Distribution channel
- 8.8.4. Market Size and Forecast By End-use
- 8.8.5. Market Size and Forecast By Ingredient Type
- 8.9. France Probiotics Market Outlook
- 8.9.1. Market Size by Value
- 8.9.2. Market Size and Forecast By Product Type
- 8.9.3. Market Size and Forecast By Distribution channel
- 8.9.4. Market Size and Forecast By End-use
- 8.9.5. Market Size and Forecast By Ingredient Type
- 8.10. Italy Probiotics Market Outlook
- 8.10.1. Market Size by Value
- 8.10.2. Market Size and Forecast By Product Type
- 8.10.3. Market Size and Forecast By Distribution channel
- 8.10.4. Market Size and Forecast By End-use
- 8.10.5. Market Size and Forecast By Ingredient Type
- 8.11. Spain Probiotics Market Outlook
- 8.11.1. Market Size by Value
- 8.11.2. Market Size and Forecast By Product Type
- 8.11.3. Market Size and Forecast By Distribution channel
- 8.11.4. Market Size and Forecast By End-use
- 8.11.5. Market Size and Forecast By Ingredient Type
- 8.12. Russia Probiotics Market Outlook
- 8.12.1. Market Size by Value
- 8.12.2. Market Size and Forecast By Product Type
- 8.12.3. Market Size and Forecast By Distribution channel
- 8.12.4. Market Size and Forecast By End-use
- 8.12.5. Market Size and Forecast By Ingredient Type
- 9. Asia-Pacific Probiotics Market Outlook
- 9.1. Market Size By Value
- 9.2. Market Share By Country
- 9.3. Market Size and Forecast, By Product Type
- 9.4. Market Size and Forecast, By Distribution channel
- 9.5. Market Size and Forecast, By End-use
- 9.6. Market Size and Forecast, By Ingredient Type
- 9.7. China Probiotics Market Outlook
- 9.7.1. Market Size by Value
- 9.7.2. Market Size and Forecast By Product Type
- 9.7.3. Market Size and Forecast By Distribution channel
- 9.7.4. Market Size and Forecast By End-use
- 9.7.5. Market Size and Forecast By Ingredient Type
- 9.8. Japan Probiotics Market Outlook
- 9.8.1. Market Size by Value
- 9.8.2. Market Size and Forecast By Product Type
- 9.8.3. Market Size and Forecast By Distribution channel
- 9.8.4. Market Size and Forecast By End-use
- 9.8.5. Market Size and Forecast By Ingredient Type
- 9.9. India Probiotics Market Outlook
- 9.9.1. Market Size by Value
- 9.9.2. Market Size and Forecast By Product Type
- 9.9.3. Market Size and Forecast By Distribution channel
- 9.9.4. Market Size and Forecast By End-use
- 9.9.5. Market Size and Forecast By Ingredient Type
- 9.10. Australia Probiotics Market Outlook
- 9.10.1. Market Size by Value
- 9.10.2. Market Size and Forecast By Product Type
- 9.10.3. Market Size and Forecast By Distribution channel
- 9.10.4. Market Size and Forecast By End-use
- 9.10.5. Market Size and Forecast By Ingredient Type
- 9.11. South Korea Probiotics Market Outlook
- 9.11.1. Market Size by Value
- 9.11.2. Market Size and Forecast By Product Type
- 9.11.3. Market Size and Forecast By Distribution channel
- 9.11.4. Market Size and Forecast By End-use
- 9.11.5. Market Size and Forecast By Ingredient Type
- 10. South America Probiotics Market Outlook
- 10.1. Market Size By Value
- 10.2. Market Share By Country
- 10.3. Market Size and Forecast, By Product Type
- 10.4. Market Size and Forecast, By Distribution channel
- 10.5. Market Size and Forecast, By End-use
- 10.6. Market Size and Forecast, By Ingredient Type
- 10.7. Brazil Probiotics Market Outlook
- 10.7.1. Market Size by Value
- 10.7.2. Market Size and Forecast By Product Type
- 10.7.3. Market Size and Forecast By Distribution channel
- 10.7.4. Market Size and Forecast By End-use
- 10.7.5. Market Size and Forecast By Ingredient Type
- 10.8. Argentina Probiotics Market Outlook
- 10.8.1. Market Size by Value
- 10.8.2. Market Size and Forecast By Product Type
- 10.8.3. Market Size and Forecast By Distribution channel
- 10.8.4. Market Size and Forecast By End-use
- 10.8.5. Market Size and Forecast By Ingredient Type
- 10.9. Colombia Probiotics Market Outlook
- 10.9.1. Market Size by Value
- 10.9.2. Market Size and Forecast By Product Type
- 10.9.3. Market Size and Forecast By Distribution channel
- 10.9.4. Market Size and Forecast By End-use
- 10.9.5. Market Size and Forecast By Ingredient Type
- 11. Middle East & Africa Probiotics Market Outlook
- 11.1. Market Size By Value
- 11.2. Market Share By Country
- 11.3. Market Size and Forecast, By Product Type
- 11.4. Market Size and Forecast, By Distribution channel
- 11.5. Market Size and Forecast, By End-use
- 11.6. Market Size and Forecast, By Ingredient Type
- 11.7. United Arab Emirates (UAE) Probiotics Market Outlook
- 11.7.1. Market Size by Value
- 11.7.2. Market Size and Forecast By Product Type
- 11.7.3. Market Size and Forecast By Distribution channel
- 11.7.4. Market Size and Forecast By End-use
- 11.7.5. Market Size and Forecast By Ingredient Type
- 11.8. Saudi Arabia Probiotics Market Outlook
- 11.8.1. Market Size by Value
- 11.8.2. Market Size and Forecast By Product Type
- 11.8.3. Market Size and Forecast By Distribution channel
- 11.8.4. Market Size and Forecast By End-use
- 11.8.5. Market Size and Forecast By Ingredient Type
- 11.9. South Africa Probiotics Market Outlook
- 11.9.1. Market Size by Value
- 11.9.2. Market Size and Forecast By Product Type
- 11.9.3. Market Size and Forecast By Distribution channel
- 11.9.4. Market Size and Forecast By End-use
- 11.9.5. Market Size and Forecast By Ingredient Type
- 12. Competitive Landscape
- 12.1. Competitive Dashboard
- 12.2. Business Strategies Adopted by Key Players
- 12.3. Key Players Market Share Insights and Analysis, 2025
- 12.4. Key Players Market Positioning Matrix
- 12.5. Porter's Five Forces
- 12.6. Company Profile
- 12.6.1. Danone S.A.
- 12.6.1.1. Company Snapshot
- 12.6.1.2. Company Overview
- 12.6.1.3. Financial Highlights
- 12.6.1.4. Geographic Insights
- 12.6.1.5. Business Segment & Performance
- 12.6.1.6. Product Portfolio
- 12.6.1.7. Key Executives
- 12.6.1.8. Strategic Moves & Developments
- 12.6.2. Yakult Honsha Co. Ltd.
- 12.6.3. Nestlé S.A.
- 12.6.4. Kerry Group plc
- 12.6.5. Evonik Industries AG
- 12.6.6. International Flavors & Fragrances Inc.
- 12.6.7. Lallemand Inc.
- 12.6.8. Arla Foods Amba
- 12.6.9. Lonza Group AG
- 12.6.10. AB-Biotics, S.A.
- 12.6.11. Probi AB
- 12.6.12. PepsiCo Inc.
- 12.6.13. BioGaia AB
- 12.6.14. Archer-Daniels-Midland Company
- 12.6.15. Novonesis
- 12.6.16. Lifeway Foods, Inc
- 12.6.17. Probiotical S.p.A.
- 12.6.18. Sacco S.r.l.
- 12.6.19. Mother Dairy Fruit & Vegetable Pvt. Ltd.
- 12.6.20. Morinaga Milk Industry Co., Ltd.
- 13. Strategic Recommendations
- 14. Annexure
- 14.1. FAQ`s
- 14.2. Notes
- 15. Disclaimer
Table 2: Influencing Factors for Probiotics Market, 2025
Table 3: Top 10 Counties Economic Snapshot 2024
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Probiotics Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
Table 7: Global Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 8: Global Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 9: Global Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 10: Global Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 11: North America Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 12: North America Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 13: North America Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 14: North America Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 15: United States Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 16: United States Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 17: United States Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 18: United States Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 19: Canada Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 20: Canada Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 21: Canada Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 22: Canada Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 23: Mexico Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 24: Mexico Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 25: Mexico Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 26: Mexico Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 27: Europe Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 28: Europe Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 29: Europe Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 30: Europe Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 31: Germany Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 32: Germany Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 33: Germany Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 34: Germany Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 35: United Kingdom (UK) Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 36: United Kingdom (UK) Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 37: United Kingdom (UK) Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 38: United Kingdom (UK) Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 39: France Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 40: France Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 41: France Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 42: France Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 43: Italy Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 44: Italy Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 45: Italy Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 46: Italy Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 47: Spain Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 48: Spain Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 49: Spain Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 50: Spain Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 51: Russia Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 52: Russia Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 53: Russia Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 54: Russia Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 55: Asia-Pacific Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 56: Asia-Pacific Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 57: Asia-Pacific Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 58: Asia-Pacific Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 59: China Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 60: China Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 61: China Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 62: China Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 63: Japan Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 64: Japan Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 65: Japan Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 66: Japan Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 67: India Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 68: India Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 69: India Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 70: India Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 71: Australia Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 72: Australia Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 73: Australia Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 74: Australia Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 75: South Korea Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 76: South Korea Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 77: South Korea Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 78: South Korea Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 79: South America Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 80: South America Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 81: South America Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 82: South America Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 83: Brazil Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 84: Brazil Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 85: Brazil Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 86: Brazil Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 87: Argentina Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 88: Argentina Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 89: Argentina Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 90: Argentina Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 91: Colombia Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 92: Colombia Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 93: Colombia Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 94: Colombia Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 95: Middle East & Africa Probiotics Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 96: Middle East & Africa Probiotics Market Size and Forecast, By Distribution channel (2020 to 2031F) (In USD Billion)
Table 97: Middle East & Africa Probiotics Market Size and Forecast, By End-use (2020 to 2031F) (In USD Billion)
Table 98: Middle East & Africa Probiotics Market Size and Forecast, By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 99: United Arab Emirates (UAE) Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 100: United Arab Emirates (UAE) Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 101: United Arab Emirates (UAE) Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 102: United Arab Emirates (UAE) Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 103: Saudi Arabia Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 104: Saudi Arabia Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 105: Saudi Arabia Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 106: Saudi Arabia Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 107: South Africa Probiotics Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 108: South Africa Probiotics Market Size and Forecast By Distribution channel (2020 to 2031F) (In USD Billion)
Table 109: South Africa Probiotics Market Size and Forecast By End-use (2020 to 2031F) (In USD Billion)
Table 110: South Africa Probiotics Market Size and Forecast By Ingredient Type (2020 to 2031F) (In USD Billion)
Table 111: Competitive Dashboard of top 5 players, 2025
Table 112: Key Players Market Share Insights and Analysis for Probiotics Market 2025
Figure 2: Market attractiveness Index, By Region 2031F
Figure 3: Market attractiveness Index, By Segment 2031F
Figure 4: Global Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Global Probiotics Market Share By Region (2025)
Figure 6: North America Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: North America Probiotics Market Share By Country (2025)
Figure 8: US Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Canada Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 10: Mexico Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 11: Europe Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 12: Europe Probiotics Market Share By Country (2025)
Figure 13: Germany Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 14: United Kingdom (UK) Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 15: France Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 16: Italy Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 17: Spain Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 18: Russia Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 19: Asia-Pacific Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 20: Asia-Pacific Probiotics Market Share By Country (2025)
Figure 21: China Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 22: Japan Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 23: India Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 24: Australia Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 25: South Korea Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 26: South America Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 27: South America Probiotics Market Share By Country (2025)
Figure 28: Brazil Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 29: Argentina Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 30: Colombia Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 31: Middle East & Africa Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 32: Middle East & Africa Probiotics Market Share By Country (2025)
Figure 33: United Arab Emirates (UAE) Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 34: Saudi Arabia Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 35: South Africa Probiotics Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Probiotics Market
Probiotics Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (27 April, 2026)
- Notify To Team (27 April, 2026)
- Report updation (28 April, 2026)
- Report Quality Check (28 April, 2026)
- Report Dispatch (29 April, 2026)
- Hard Copy
Recently Viewed Products
Global Probiotics Market Outlook, 2031
We are friendly and approachable, give us a call.